- Research works
- 45 ▲ 29% vs 2018-21
- Citations
- 2.1k 45.5 per fractional work
- Top-10% rate
- 8.3% all institutions 10.0%
- Open access
- 51% world 40%
- International
- 16% world 18%
Not ranked overall: Progenra (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Progenra (United States) work in?
In all years, 69% of research at Progenra (United States) is in Life Sciences, 24% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (62%), Medicine (24%), Immunology and Microbiology (6%). It does 3.5× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 14 fields, with their numbers
- Life Sciences3168.9%
- Health Sciences1123.7%
- Medicine1123.7%
- Physical Sciences25.3%
- Engineering13.0%
- Earth and Planetary Sciences00.7%
- Environmental Science00.7%
- Chemistry00.7%
- Computer Science00.1%
- Social Sciences12.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.4×. Every wedge is a field page.
All 6 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics8.40×0 works
- Biochemistry, Genetics and Molecular Biology5.89×2 works
- Medicine2.96×3 works
- Economics, Econometrics and Finance1.38×0 works
- Engineering0.24×0 works
- Social Sciences0.18×0 works
Who are the top researchers at Progenra (United States)?
Ranked on the quality score, Michael R. Mattern, Suresh Kumar and Benjamin Thomas Nicholson lead among researchers whose main affiliation is Progenra (United States).
- 1
Michael R. Mattern
United States · #272,878 worldwide 8.6k citations · 126 works
- 2
Suresh Kumar
United States · #293,432 worldwide 4.3k citations · 64 works
- 3
Benjamin Thomas Nicholson
United States · #334,342 worldwide 5.5k citations · 105 works
- 4
Tauseef R. Butt
United States · #380,657 worldwide 6.2k citations · 97 works
- 5
David E. Sterner
United States · #389,757 worldwide 4.7k citations · 40 works
- 6
Seth J. Goldenberg
United States · #671,206 worldwide 2.2k citations · 25 works
- 7
Matthew P. Kodrasov
United States · #1,490,348 worldwide 1k citations · 16 works
- 8
Craig A. Leach
United States · #1,711,582 worldwide 2k citations · 34 works
- 9
Jian Wu
United States · #4,384,763 worldwide 2.6k citations · 177 works
Which keywords describe research at Progenra (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Proteasome Inhibitors, Proteasome, Ubiquitin, Tumor Microenvironment, Transcriptional Regulation, BET Bromodomains and PROTACs.
- Parkinson's Disease
- Glycans
- HIF-1
- Oxidative Stress
- Cell Death
- Immunity
- Regulation
- Mutation
- HDAC Inhibitors
- Immunosuppression
- PET Imaging
- Gene Expression
- Cancer
- Transcriptional Regulation
- Ubiquitin
- Proteasome Inhibitors
- Cancer Therapy
- Proteasome
- Tumor Microenvironment
- BET Bromodomains
- PROTACs
- Apoptosis
- Fibroblast Activation Protein
- Epigenetic Regulation
- Histone Deacetylases
- Cell Cycle
- p53
- Immune System
- Inflammation
- Glycosylation
- Warburg Effect
- Mucins
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Cancer Therapy22▲ 77×7 topics
- Proteasome Inhibitors14▲ 441×2 topics
- Proteasome14▲ 755×1 topic
- Ubiquitin14▲ 755×1 topic
- Tumor Microenvironment5▲ 33×4 topics
- Transcriptional Regulation4▲ 38×2 topics
- BET Bromodomains4▲ 447×1 topic
- Cancer4▲ 6.5×10 topics
- PROTACs4▲ 447×1 topic
- Gene Expression4▲ 13×3 topics
- Apoptosis4▲ 20×5 topics
- PET Imaging3▲ 31×2 topics
- Fibroblast Activation Protein3▲ 129×1 topic
- Immunosuppression3▲ 57×1 topic
- Epigenetic Regulation3▲ 29×2 topics
- HDAC Inhibitors3▲ 296×1 topic
- Histone Deacetylases3▲ 296×1 topic
- Mutation2▲ 35×2 topics
- Cell Cycle2▲ 79×1 topic
- Regulation2▲ 7.7×2 topics
- p532▲ 105×1 topic
- Immunity2▲ 13×5 topics
- Immune System2▲ 11×3 topics
- Cell Death2▲ 16×4 topics
- Inflammation2▲ 1.37×4 topics
- Oxidative Stress1▲ 1.62×4 topics
- Glycosylation1▲ 12×2 topics
- HIF-11▲ 32×1 topic
- Warburg Effect1▲ 32×1 topic
- Glycans1▲ 28×1 topic
- Mucins1▲ 28×1 topic
- Parkinson's Disease1▲ 9.7×2 topics
Which research topics does Progenra (United States) publish most on?
By volume in 2022-now: Ubiquitin and proteasome pathways, Medication Adherence and Compliance, Autophagy in Disease and Therapy and SARS-CoV-2 and COVID-19 Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 2 Medication Adherence and Compliance Family Practice 1 works
- 3 Autophagy in Disease and Therapy Epidemiology 0 works
- 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 5 Microtubule and mitosis dynamics Cell Biology 0 works
- 6 Influenza Virus Research Studies Epidemiology 0 works
- 7 SARS-CoV-2 detection and testing Infectious Diseases 0 works
- 8 Cancer-related Molecular Pathways Oncology 0 works
- 9 Pharmaceutical industry and healthcare Pharmacology 0 works
- 10 Protein Degradation and Inhibitors Molecular Biology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Progenra (United States)'s research output changed?
Output in 2022-2025 was 29% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Progenra (United States) as a percentage of every work published that year, 0.0000098% in 2024.
Fractional works of Progenra (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Malvern
- Siemens Healthcare (United States)
- Endo Pharmaceuticals (United States)
- Immaculata University
- Ricoh (United States)
- Reaction Biology Corporation (United States)
- Applied Pulsed Power (United States)
- TetraLogic Pharmaceuticals (United States)
- Saint-Gobain (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Progenra (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.